Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -10.81 | -16.22 |
PEG Ratio (TTM) | -3.35 | -1.41 |
P/S Ratio (TTM) | N/A | 48.82 |
P/B Ratio (TTM) | 3.46 | 21.13 |
P/FCF Ratio (TTM) | -15.01 | 9.38 |
Price to 5YR AVG Earnings Ratio | -9.65 | -0.21 |
Price to 5YR AVG FCF Ratio | -18.42 | -7.10 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -29.32% | -3.10% |
ROE (TTM) | -30.62% | 24.21% |
Net Profit Margin (TTM) | N/A | -1,069.78% |
ROIC 5YR AVG | 966.52% | 16.50% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -0.84% | -13.93% | -10.68% |
Revenue | N/A | N/A | N/A |
Net Income | -3.26% | -31.62% | -24.08% |
Cash Flow | -1.32% | -34.96% | -19.86% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 12.04 | 5.75 |
Quick Ratio (TTM) | 12.04 | 5.47 |
D/E Ratio (TTM) | -0.01 | -15.13 |
Interest Coverage (TTM) | 140,805.78 | 3.59 |
Piotroski F-Score | 1 | 5 |
Altman Z-Score | 19.89 | 13.47 |
LTL to 5YR AVG FCF | N/A | 0.20 |
Shares Outstanding Growth 5YR AVG | 12.48% | 118.86% |